Impact Of Decreasing Copayments On Medication Adherence Within A Disease Management Environment

This paper estimates the effects of a large employer's value-based insurance initiative designed to improve adherence to recommended treatment regimens. The intervention reduced copayments for five chronic medication classes in the context of a disease management (DM) program. Compared to a con...

Full description

Saved in:
Bibliographic Details
Published in:Health Affairs 2008-01, Vol.27 (1), p.103-112
Main Authors: Chernew, Michael E, Shah, Mayur R, Wegh, Arnold, Rosenberg, Stephen N, Juster, Iver A, Rosen, Allison B, Sokol, Michael C, Yu-Isenberg, Kristina, Fendrick, A. Mark
Format: Article
Language:English
Subjects:
Chronic illnesses
Contraindications
Cost control
Disease management
Drug therapy
Drugs
Employees
Employers
Health care expenditures
Health insurance
Initiatives
Intervention
Patient compliance
Prescription drugs
Studies
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:This paper estimates the effects of a large employer's value-based insurance initiative designed to improve adherence to recommended treatment regimens. The intervention reduced copayments for five chronic medication classes in the context of a disease management (DM) program. Compared to a control employer that used the same DM program, adherence to medications in the value-based intervention increased for four of five medication classes, reducing nonadherence by 7-14 percent. The results demonstrate the potential for copayment reductions for highly valued services to increase medication adherence above the effects of existing DM programs. [PUBLICATION ABSTRACT]
ISSN:0278-2715
1544-5208
DOI:10.1377/hlthaff.27.1.103